The Arnold & Porter capital markets practice regularly advises on a broad range of equity offerings including initial public offerings, private placements and secondary offerings. The team is also well regarded for its work for sovereigns, state-owned companies and international financial institutions on sovereign bond issuances, liability management transactions, derivatives operations and refinancings. The practice is co-led by New York-based Michael Penney and Christopher Peterson. Johnson advises clients on securities transactions and compliance matters, Penney is noted for his corporate expertise. Teresa Johnson  departed the firm in February 2026.

Baker Botts L.L.P. is highly regarded by both issuers and underwriters in the energy sector, with particular strengths in IPOs, MLPs, structured equity products and M&A-related transactions. The practice is jointly led by Dallas-based Samantha Hale Crispin and Houston-based Doug Getten. Getten regularly advises public companies on corporate governance, securities law disclosure and compliance matters including Section 16 reporting obligations. Hale Crispin is a seasoned M&A practitioner who counsels corporate clients across a broad range of capital markets transactions. Evan Koster concentrates on sovereign finance and also represents financial institutions and corporate borrowers in emerging markets.

The Baker McKenzie capital markets practice combines a broad and diversified securities regulation, corporate governance and capital markets platform with deep corporate law experience. The team advises US public companies and foreign issuers frequently on cross-border matters, and is active across private placements, IPOs and follow-on equity offerings. The practice is led by New York-based Mark Mandel, who is particularly noted for his work on M&A-related transactions. Cyerra McGowan joined the firm in June 2025 from Latham & Watkins, bringing a wealth of knowledge in public and private offerings. Christopher Lapp departed the firm in May 2025.

The Bracewell LLP capital markets practice represents issuers and underwriters across a broad spectrum of public offerings, private placements, equity financings and complex securities transactions. The group is led from Houston by Troy Harder, who is recognised for his strength in corporate finance transactions. Shannon Baldwin focuses on mergers and acquisitions, joint ventures and MLP dropdown transactions. Stephen McNamara is noted for his work on SEC-registered offerings, Rule 144A issuances, private placements and tax-exempt financings. Catherine Hood retired from the firm in October 2025.

Cleary Gottlieb Steen & Hamilton brings a wealth of knowledge across the full spectrum of capital markets transactions, with the New York-based team particularly noted for its experience in international IPOs, SPAC-related matters and broader cross-border offerings. Jeffrey Karpf represents issuers, sponsors and investment banks in IPOs and other public and private offerings of equity, debt and convertible securities. David Lopez focuses on liability management matters including issuer self-tenders, exchange offers, consent solicitations and open market repurchase strategies. Craig Brod is recognized for his work on SEC reporting and crisis management situations, while Adam Fleisher regularly advises alternative asset managers on succession planning, governance, firm restructurings and private placements. Adam Brenneman departed the firm in May 2025, Ilir Mujalovic and Harald Halbhuber joined the team in February 2026 from A&O Shearman.

The Clifford Chance capital markets practice advises fund sponsors and underwriters on equity transactions, with recognised experience with the launch of US closed-end funds. The New York-based team is jointly led by Andrew Epstein and Jonathan Zonis. Zonis focuses on cross-border equity offerings, while Epstein brings multi-sector experience spanning finance, asset management, real estate, hospitality and healthcare. Mariana Estévez advises financial institutions on innovative financing structures, including securitisations and bank-bond structures, for energy and infrastructure projects across Latin America. Jake Farquharson represents sponsors, issuers and investment banks in public and private capital raises. Om Pandya joined the firm from Latham & Watkins, and Jason Parsont departed in September 2024.

The Cooley LLP capital markets practice advises issuers and underwriters across the full spectrum of equity offerings. The group, which is jointly led by Charlie Kim and David Peinsipp, brings particular strength with initial public offerings in the technology, healthcare and life sciences sectors. In San Francisco, Peinsipp excels in a broad range of sophisticated securities offerings including direct listings, follow-on offerings, Rule 144A transactions and private investments in public equity. In San Diego, Kim is a leading advisor on equity and debt issuances, with a strong focus on technology and consumer sector companies. In the New York office, Div Gupta is regularly retained by investment banks across industries and is well regarded for his work on initial public offerings of common stock. Fellow New York IPO specialist Richard Segal is highly active across the technology, consumer and retail sectors. In Chicago, Christina Roupas counsels public companies on disclosure obligations, corporate governance and compliance matters. Partner Jonie Kondracki departed the firm in October 2025.

The Cravath, Swaine & Moore LLP equity capital markets practice advises issuers and underwriters across the full range of equity offerings including initial public offerings, secondary offerings, equity-linked transactions and related derivatives matters. The New York-based practice is led by Craig Arcella and Andrew Pitts. Arcella focuses on IPOs, liability management transactions, as well as investment-grade and convertible bond offerings. Corporate finance specialist Pitts is particularly noted for his work on convertible and other equity-linked securities transactions. William Fogg retired in March 2026.

Davis Polk & Wardwell LLP brings extensive experience to capital markets matters, representing a broad base of domestic and international issuers and underwriters across a wide range of equity offerings. The firm is highly active on leveraged finance and equity capital markets transactions including high-value IPOs and follow-on offerings, with particular strength in the technology and healthcare sectors. The practice is led by Maurice Blanco, Michael Kaplan, John Meade and Richard Truesdell. Kaplan excels in transactions across the technology, telecommunications and basic industry sectors, while Truesdell advises on related corporate governance and securities regulation matters. Meade brings experience to secondary equity offerings, split-off exchanges and complex structural transactions. In Northern California, Alan Denenberg is noted for his work on equity and debt financings across the technology, healthcare, telecommunications, retail and transportation sectors. Derek Dostal is particularly active in the SPAC space, while Byron Rooney advises on IPOs, direct listings and private placements. Roshni Banker Cariello is recognized for her work on investment-grade, high-yield and convertible debt financings, as well as liability management transactions.

The Debevoise & Plimpton LLP capital markets practice advises on SPAC and PIPE transactions, financings, capital raises and exit transactions. The team often represents clients on offerings exempt from SEC registration under Rule 144A and Regulation S, as well as spin-offs, debt tender offers, restructurings and connected M&A transactions. The New York-based group is co-led by Paul Rodel and Steven Slutzky. Rodel advises on initial public offerings, secondary and follow-on offerings, private placements and debt offerings, while Slutzky is particularly noted for his work on high-yield debt offerings, tender offers and consent solicitations. Matthew Kaplan counsels public and private companies on disclosure, corporate governance and financing matters. Peter Loughran regularly advises on US and international securities offerings.

Leveraging its cross-border platform across the US, Europe and Asia, the Dechert capital markets group is well placed to advise on the full spectrum of public and private debt, equity, equity-linked and other securities offerings. The team is led by Boston-based Thomas Friedmann, Philadelphia-based Stephen M Leitzell, and Washington DC-based Harry Pangas. Pangas is recognised for his strength in negotiating, executing mergers, joint ventures and strategic transactions. Friedmann regularly advises alternative asset managers in their efforts to access permanent capital through Business Development Companies, closed-end funds and other vehicles. Leitzell advises on securities offerings, financings and public company governance matters. Rafe Khokhar departed in April 2025.

The DLA Piper LLP (US) capital markets team advises global investment banks, institutional investors, as well as domestic and foreign issuers on a wide range of equity transactions. The group is recognised for its work on innovative deals across the digital assets, technology, life sciences and consumer sectors. The practice is led by New York-based Josh Kaufman and Washington, DC-based Era Anagnosti. Kaufman focuses on advising high-growth companies on strategic development and transformational transactions. Anagnosti is noted for her corporate governance expertise, regularly counselling on disclosure and compliance matters. Stephen Alicanti adds further depth with experience in registered offerings and private placements of equity securities. Bianca LaCaille excels in international and going-private transactions.

The Fenwick & West LLP capital markets practice advises both issuers and underwriters on equity offerings, with particular strength in the technology and life sciences sectors. The team, led by Santa Monica based Ran Ben-Tzur and Seattle based Amanda Rose, is noted for its experience across both traditional and innovative public offering structures including SPAC transactions, direct listings and reverse mergers. Ben-Tzur advises high-growth private and public technology companies particularly in the software, social networking, fintech, crypto, internet and mobility spaces. Rose is recognised for her expertise in corporate finance, SEC reporting and governance matters.

The bi-coastal capital markets practice at Freshfields is particularly strong in the technology and life sciences sectors, advising issuers and underwriters on a broad range of equity transactions. The practice is led by Sarah Solum in Silicon Valley and Pamela Marcogliese in New York. Solum brings extensive experience across IPOs, direct listings,  convertible note deals and preferred stock financings. Marcogliese is widely recognized for her work on IPOs, direct listings and SPAC transactions. Calise Cheng provides support for companies in the tech industry, alongside Phillip Stoup who brings a wealth of knowledge to the life sciences industry. Taryn Zucker is noted for selling security holders in IPOs. Erik Gerding joined the firm in January 2025, bringing deep regulatory expertise across the corporate lifecycle. Chris DeCresce departed the team in February 2026.

Fried, Frank, Harris, Shriver & Jacobson LLP regularly represents domestic and international issuers, underwriters and private equity firms on sophisticated capital markets transactions. The team is active across a broad range of industries including telecommunications, retail, finance, technology, real estate, insurance, HR and marketing. The New York practice is led by Daniel Bursky, Andrew Barkan and Joshua Wechsler. Bursky focuses on convertible securities, high-yield debt offerings and private placements, while Wechsler advises on IPOs, investment-grade debt offerings and cross-border financings. Barkan is particularly active in follow-on and secondary equity offerings, acquisition financings, debt tender offers and consent solicitations. Mark Hayek brings additional strength in leveraged loan transactions, while Monica Thurmond is recognised for her work on private placements of convertible debt and preferred stock.

Gibson, Dunn & Crutcher LLP regularly advises issuers, underwriters and investors on sophisticated equity and preferred financing programs, including at-the-market offerings, initial public offerings, private placements and take-private transactions. The practice is co-led by Hillary Holmes, Andrew Fabens, Stewart McDowell and Peter Wardle. New York-based Fabens and Wardle are particularly noted for their work on hybrid offerings and liability management transactions. From Houston, Holmes brings strong corporate governance expertise, while San Francisco-based McDowell advises clients on common stock offerings and related capital raises. Melanie Neary represents life sciences companies and investors in IPOs, follow-on equity, PIPE and ATM.

The Goodwin capital markets practice regularly advises on follow-on offerings, secondary sales, block trades and liability management transactions, with a focus on aligning each financing with a company’s capital structure, shareholder profile and long-term growth strategy. Beyond traditional IPOs, the team is active in alternative financing structures, including at-the-market programs and PIPE transactions. The practice is led by Edwin O’Connor in New York, alongside Bradley Weber in Silicon Valley and James Barri in Boston. O’Connor has particular experience advising on capital markets transactions in the life sciences, technology and clean tech sectors. Weber is recognised for his strength in complex securities law matters and sophisticated transactional issues. Barrie adds further depth to the bench, advising issuers and underwriters on a range of equity capital markets transactions. Bryan Quinn departed the firm in July 2025.

The Hogan Lovells US LLP capital markets practice is a prominent issuer-focused group with particular strength in the life sciences, healthcare, real estate and technology sectors. The team regularly advises on a broad range of equity offerings and is recognised for its public company advisory capabilities across their Washington DC, New York, Northern Virginia, Baltimore and Philadelphia offices. The practice is led by Richard Aftanas from the New York office, who is highly experienced in IPOs and investment-grade debt offerings. Also from the New York office Rupa Briggs advises on de-SPAC business combinations, IPOs and follow-on equity offerings. In Philadelphia, Steve Abrams is particularly active in the life sciences and healthcare sector. Kevin Greenslade from Northern Virginia focuses on Rule 144A private placements of high-yield debt securities and registered public offerings of investment-grade debt.

Hunton Andrews Kurth LLP delivers comprehensive capital markets counsel across the power and utilities, consumer products, retail, energy and real estate sectors. Representing investors, domestic issuers and underwriters, the practice is led by Philip Haines, Peter O’Brien and Robert Smith. Houston-based Haines advises on corporate governance, periodic reporting obligations and day-to-day securities law compliance matters. New York-based O’Brien is particularly experienced in REIT transactions and SEC compliance issues, while Washington DC-based Smith brings extensive experience advising on M&A, REITs and other real estate-focused companies. Michael Fitzpatrick excels across equity hybrid instruments, collateral trust bonds and dedicated utility rate securitisation bonds.

Issuers, sellers and underwriters turn to King & Spalding for representation in public and private offerings of equity securities. The practice has a strong sector focus spanning energy, financial institutions, life sciences and healthcare, real estate, and telecommunications. The capital markets group is co-led by Keith Townsend, Elizabeth Morgan and Cal Smith. Atlanta-based Townsend and Smith both focus on capital markets transactions and corporate governance matters, while New York-based Morgan is particularly noted for her expertise in disclosure and reporting issues. Allison Bell joined the firm in May 2025 from Kirkland & Ellis LLP, further strengthening the capabilities of the team.

Leveraging its global platform, Kirkland & Ellis LLP offers strength across the full spectrum of capital markets activity. The team is particularly noted for its work on equity offerings for private equity firms and their portfolio companies, as well as for public companies and underwriters on high-yield note offerings, initial public offerings, acquisition financings and direct investments by private equity sponsors in public companies. New York based Joshua Korff is recognised for his work on IPOs, high-yield offerings, acquisition finance and complex restructurings, while Chicago based Robert Hayward is noted for his expertise in M&A, spin-offs, disclosure, crisis management and broader corporate matters. The practice was further strengthened by the arrival of Katherine Shaia from Paul, Weiss, Rifkind, Wharton & Garrison LLP.

The ‘innovative and client-focused’ Latham & Watkins capital markets team advises issuers and underwriters across the full spectrum of equity offerings. The group supports companies throughout their lifecycle, delivering strategic capital-raising solutions at each stage of growth. It is particularly well regarded for assisting non-US issuers accessing the US capital markets and for navigating the regulatory and structural complexities of cross-border transactions. New York-based IPO specialist Marc Jaffe represents leading companies, investment banks, private equity and venture capital funds on a broad range of equity offerings. In San Francisco, Rick Kline is noted for his work for technology-sector innovators and their financiers, while Gregory Rodgers is especially active in US direct listings and convertible debt transactions. Ian Schuman brings extensive transactional experience spanning IPOs, follow-on offerings, convertible note offerings and high-yield debt deals. Alison Haggerty is recognized for her work on capital markets transactions for US investment banks and innovative companies in the technology and life sciences sectors.

McDermott Will & Schulte has strong expertise across a broad range of equity capital markets transactions including IPOs, follow-on offerings and private placements. Chicago-based Eric Orsic co-leads the practice and is noted for his work on public equity, tender offers and going-private transactions. Washington DC-based Thomas Conaghan co-leads the department and advises both US and foreign public companies. The arrival of Craig Garvey from Kirkland & Ellis LLP in May 2025 brought additional depth in high-yield note offerings and issuer-side IPOs to the group. The team was further strengthened by the firm’s broader merger with Schulte Roth & Zabelin in August 2025.

Milbank advises issuers, underwriters and sovereigns across a wide range of capital markets transactions. The practice is led from New York by Jonathon Jackson, who has extensive experience in corporate finance transactions and special situation investment opportunities, with particular expertise in high-yield and hybrid capital, preferred equity, and initial public offerings. Rod Miller is regularly instructed by investment banks on high-profile equity and debt offerings, especially those tied to M&A financings and other strategic transactions. Brett Nadritch contributes strength in asset securitizations and structured transportation finance. The bench was further enhanced by the arrival of Adam Brenneman, who joined the firm in May 2025 from Cleary Gottlieb Steen & Hamilton.

The Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. capital markets practice is widely recognised for advising managers on equity transactions in the life sciences and biotech sectors. The group is led by John Rudy in Boston and Daniel Bagliebter in New York. Bagliebter focuses on securities offerings and mergers and acquisitions, with particular strength in IPOs and follow-on public offerings, while Rudy brings extensive experience across equity and debt financings, securities matters and general corporate advisory work. The bench was further strengthened by the arrival of Alok Choksi, who joined the firm from Haynes and Boone, L.L.P. in April 2025.

The Morrison Foerster capital markets practice has broad expertise across a range of equity products including initial public offerings, secondary offerings, at-the-market offerings, private investments in public equity and Rule 144A offerings. The team is led by Washington, DC-based Justin Salon, a recognised specialist in corporate governance and securities law matters. Andy Campbell is noted for his extensive experience advising REIT clients and is frequently involved in capital markets transactions with M&A elements. Texas-based John Hensley is also highlighted for his strong insight into securities law matters.

The Nelson Mullins Riley & Scarborough LLP capital markets practice focuses on a broad range of equity offerings, including initial and follow-on public offerings, at-the-market programs, bought deals, shelf takedowns, PIPE transactions, direct listings and SPAC-related offerings. The practice is led from Washington DC by Jonathan Talcott who regularly guides clients through IPOs, follow-on offerings, confidentially marketed public offerings and Rule 144A equity offerings. David Mannheim has a particular focus on life sciences, technology, and clean energy businesses. Michael Rafter represents public non-traded REITs and regularly counsels real estate sponsors on REIT formations and accessing non-traded broker-dealer and registered investment advisor distribution channels.

The O'Melveny capital markets practice provides comprehensive counsel to both issuers and underwriters across a wide array of equity transactions. With the group having notable experience in the energy, real estate and pharmaceutical sectors, with regular involvement in public equity offerings and PIPE financings. New York-based practice head Jeeho Lee advises clients on IPOs, secondary offerings and private placements. In San Francisco, Brophy Christensen excels in initial public offerings, follow-on offerings and convertible offerings. David Ni joined the firm in January 2025, while Michelle Earley departed in August 2024.

The Orrick, Herrington & Sutcliffe capital markets department advises on a broad range of equity transactions for both issuers and underwriters, with particularly strong experience in the technology and healthcare sectors. Practice head Albert Vanderlaan, based in Boston, focuses on high-growth technology and life sciences companies, advising on IPOs, follow-on offerings, compliance and disclosure obligations. Brett Cooper specialises in corporate finance and represents US, Canadian, European and Asian issuers and underwriters in securities law matters, M&A and general corporate work. Jamie Evans is noted for his strength in technology-sector public offerings, while Alice Hsu brings particular experience in the energy and financial services industries.

With a practice focused on issuers, the Paul, Weiss, Rifkind, Wharton & Garrison LLP team regularly handles equity offerings and the full range of registered public offerings, Rule 144A transactions and Regulation S offerings. The practice is led by John Kennedy, Brian Janson, Gregory Ezring and Eric Wedel. Janson is particularly experienced in leveraged finance transactions and corporate governance matters, while Kennedy represents both issuers and underwriters in private securities offerings. Ezring is well regarded for his work on debt restructurings and public equity offerings. Wedel is particularly noted for advising private equity sponsors and their portfolio companies on complex acquisition financings.

Domestic and international managers commend the capital markets team at Pillsbury Winthrop Shaw Pittman LLP for its regular involvement in IPOs and SPAC transactions, with particular strength in the technology and life sciences sectors. The practice is jointly led by Christina Pearson and Davina Kaile in Silicon Valley, as well Jeffrey Delaney in New York. Kaile is especially noted for her work on confidentially marketed public offerings, PIPEs and ATM transactions. Pearson and Delaney both bring substantial IPO experience, while Gabriella Lombardi adds broad capability across mergers and acquisitions and corporate finance transactions.

The ‘commercially focused’ Sidley Austin LLP capital markets practice has extensive experience across equity offerings, including secondary public offerings and complex IPOs. The team acts predominantly for domestic and international underwriters and is led from New York by Samir Gandhi, who advises corporate clients on disclosure and governance matters, complex financing structures, public offerings and private placements. Adam Gross excels in securities laws and disclosure matters. The practice was bolstered by the arrival of Natalie Karam from Cooley LLP in December 2024, followed by David Stewart and Vladimir Mikhailovsky from Latham & Watkins in April 2025. Johnny Skumpija departed in October 2025 and Kenny Terrero left the firm in November 2025.

Simpson Thacher & Bartlett LLP is frequently entrusted with complex capital markets transactions, representing issuers and underwriters across the full range of equity offerings. The team is particularly experienced in the aviation, energy and retail sectors, often managing multiple offerings of ordinary and common shares. The group is led by Joshua Ford Bonnie in Washington DC, alongside Kenneth Wallach and Roxane Reardon in New York. Bonnie is a preeminent IPO lawyer who regularly advises public companies on spin-offs, strategic transactions and broader securities law matters. Reardon counsels corporates and investment banks on complex, multi-tranche capital markets transactions. Wallach focuses his practice on high-yield offerings, IPOs, restructurings and corporate governance issues. Joseph Kaufman excels in corporate governance issues. William Brentani excels in follow-on equity and preferred stock offerings. John Ericson has extensive corporate finance experience including secondary offerings, investment grade debt offerings and acquisition finance. Niels Jensen joined the firm in April 2025, from Vinson & Elkins LLP.

Skadden, Arps, Slate, Meagher & Flom LLP provides comprehensive counsel across equity capital markets transactions for both issuers and underwriters. The group is recognised for its role in high-profile IPOs, follow-on offerings and complex cross-border equity financings, with notable experience across the biotechnology, fintech, insurance, real estate, energy, technology and consumer products sectors. The practice is led by New York-based Ryan Dzierniejko who focuses on venture capital financings and IPOs for unicorn companies. David Goldschmidt is a recognized expert in private placements of debt and equity securities, while Michael Schwartz is noted for his extensive experience in equity offerings, investment-grade debt issuances and complex refinancing transactions. Laura Kaufmann Belkhayat adds further depth with her expertise in spin-offs, liability management and restructuring matters. Gregory Fernicola regularly counsels corporate clients with respect to corporate governance and securities law matters.

Issuers and managers turn to the Vinson & Elkins LLP capital markets practice for ‘efficient and practical advice’ on a wide range of equity transactions. The group is recognised for its cross-sector capabilities, with particular strength in the energy, financial services, real estate and healthcare industries. In Austin, Thomas Zentner has built a robust practice advising private equity-backed companies on exits through the public markets as well as complex sale transactions. Houston-based Jackson O’Maley regularly counsels clients on IPOs, M&A, and other strategic matters, while fellow Houston partner Scott Rubinsky is noted for his experience in SPAC business combination transactions.

From New York, Alexander Lynch and Michael Hickey lead the Weil, Gotshal & Manges LLP capital markets practice. The team brings substantial experience across the full range of public and private transactions including IPOs, secondary and follow-on equity offerings, acquisition financings, private placements and equity-linked securities. Lynch regularly advises leading private equity sponsors, their portfolio companies and investment banks on IPOs, strategic investments and private placements. Hickey focuses on advising financial institutions on financing matters and more broadly represents clients in secondary sales, preferred equity investments, high-yield and investment-grade debt offerings. Merritt Johnson is recognized for his strength in secondary equity offerings, leveraged buyouts and liability management transactions. Barbra Broudy focuses on acquisition finance and regularly advises both issuers and underwriters on a broad range of public and private securities offerings.

With a national footprint spanning New York, Miami, Washington DC, Houston, and Los Angeles, the White & Case LLP equity capital markets team advises issuers and underwriters on a broad range of capital market transactions. The group handles IPOs, follow-on offerings, business combinations, at-the-market programs and secondary offerings,. The practice is headed by Gary Kashar in New York, who serves as regional section head of the capital markets group. A.J. Ericksen is particularly experienced in the energy sector and advises on liability management transactions, debt tender offers and consent solicitations. Jason Rocha focuses on IPOs, private investments in public equity and Rule 144A offerings. Drew Valentine, who joined the firm from DLA Piper LLP (US), brings a sector focus on AI, quantum computing and semiconductor companies. Elliott Smith and Edward So departed the firm.

Drawing on the firm’s strong cross-border platform the Willkie Farr & Gallagher LLP capital markets team is well known for handling complex IPOs and other securities offerings. The practice which is regularly instructed by both U.S. and international issuers, is jointly led in New York by Gregory Astrachan, Edward Best and Cristopher Greer. Astrachan regularly represents corporations and their boards on governance matters, while Greer excels in SEC matters as well as restructurings. Having joined the firm from Mayer Brown in August 2024, Best brings a wealth of experience with hybrid securities offerings as well as liability management transactions.

The WilmerHale capital markets practice is recognised for its strength in equity transactions across the life sciences and technology sectors. The team represents both issuers and investment banking firms in IPOs, follow-on offerings, PIPE placements, and Rule 144A transactions. New York-based Brian Johnson brings particular expertise in compliance and disclosure matters. Also based in New York is Lisa Firenze who is well versed in spin-offs, convertible note offerings and SPAC transactions. Caroline Dotolo is recognised for her strength in mergers and acquisitions, while Judith Hasko and Mick Bain offer practice on a broad range of corporate transactions.

The Winston Taylor capital markets practice advises on a broad spectrum of equity transactions including IPOs, follow-on offerings, registered direct offerings, confidentially marketed offerings, preferred stock and ADR issuances, Rule 144A global offerings and PIPE transactions. The group is co-led by Houston-based Mike Blankenship and New York-based David Sakowitz. Blankenship focuses on corporate finance, M&A, private equity, SPAC offerings and securities law matters. Sakowitz brings extensive experience advising on high-yield debt, equity and equity-linked securities across SEC-registered, Rule 144A, Regulation S and private placement transactions. Adam Howard joined the firm in February 2025, having moved from Skadden, Arps, Slate, Meagher & Flom LLP.